J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Demise
Demise of Mr. Ranjit Shahani - Chairman and Independent Director09-03-2024
09-03-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for Postal Ballot09-03-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice08-03-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Intimation Of Schedule Of Analysts/Institutional Investors Meet
Intimation of schedule of Analysts/ Institutional investors meet07-03-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme05-03-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement Under Regulation 30 - Grant Of Options Under Employee Stock Option Scheme
Grant of Options under Employee Stock Option Scheme29-02-2024
KKR ConsidersSelling Stake In India's $3 Billion JB Pharma, Sources Say
KKR & Co. is exploring options including selling its controlling stake in India's JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.28-02-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement Under Regulation 30 - Grant Of Options Under Employee Stock Option Scheme
Grant of Options under Employee Stock Option Scheme22-02-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Investors/Analysts call12-02-2024
JB Chemicals Guides For 25-27% Ebidta Margin In FY25
The company aims to increase the share of chronic segment in their portfolio from 52% to 60%, with the help of existing and niche products that it has acquired.08-02-2024